139 related articles for article (PubMed ID: 10706486)
1. Pituitary adenylate cyclase-activating peptide 38 a potent endogenously produced dilator of human airways.
Kinhult J; Andersson JA; Uddman R; Stjärne P; Cardell LO
Eur Respir J; 2000 Feb; 15(2):243-7. PubMed ID: 10706486
[TBL] [Abstract][Full Text] [Related]
2. Pituitary adenylate cyclase activating peptide (PACAP) in guinea-pig lung: distribution and dilatory effects.
Cardell LO; Uddman R; Luts A; Sundler F
Regul Pept; 1991 Nov; 36(3):379-90. PubMed ID: 1811273
[TBL] [Abstract][Full Text] [Related]
3. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
4. Helospectin, induces a potent relaxation of human airways in vitro.
Cardell M; Cardell LO
Peptides; 2001 Sep; 22(9):1359-62. PubMed ID: 11514015
[TBL] [Abstract][Full Text] [Related]
5. Helospectin/helodermin-like peptides in guinea pig lung: distribution and dilatory effects.
Cardell LO; Sundler F; Uddman R
Regul Pept; 1993 Jun; 45(3):435-43. PubMed ID: 8351407
[TBL] [Abstract][Full Text] [Related]
6. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L; Ahrén B; Edgren G; Degerman E
Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
[TBL] [Abstract][Full Text] [Related]
8. Presence and effects of pituitary adenylate cyclase activating peptide in the submandibular gland of the ferret.
Tobin G; Asztély A; Edwards AV; Ekström J; Håkanson R; Sundler F
Neuroscience; 1995 May; 66(1):227-35. PubMed ID: 7637871
[TBL] [Abstract][Full Text] [Related]
9. Distinct receptors mediate pituitary adenylate cyclase-activating peptide- and vasoactive intestinal peptide-induced relaxation of rat ileal longitudinal muscle.
Ekblad E; Sundler F
Eur J Pharmacol; 1997 Sep; 334(1):61-6. PubMed ID: 9346329
[TBL] [Abstract][Full Text] [Related]
10. Bronchodilation by pituitary adenylate cyclase-activating peptide and related peptides.
Lindén A; Cardell LO; Yoshihara S; Nadel JA
Eur Respir J; 1999 Aug; 14(2):443-51. PubMed ID: 10515428
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland.
Simonneaux V; Kienlen-Campard P; Loeffler JP; Basille M; Gonzalez BJ; Vaudry H; Robberecht P; Pévet P
Neuroscience; 1998 Aug; 85(3):887-96. PubMed ID: 9639281
[TBL] [Abstract][Full Text] [Related]
12. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
[TBL] [Abstract][Full Text] [Related]
13. The induction of nitric oxide-mediated relaxation of human isolated pulmonary arteries by PACAP.
Cardell LO; Hjert O; Uddman R
Br J Pharmacol; 1997 Mar; 120(6):1096-100. PubMed ID: 9134222
[TBL] [Abstract][Full Text] [Related]
14. Vascular effects of pituitary adenylate cyclase activating peptide: a comparison with vasoactive intestinal peptide.
Absood A; Chen D; Wang ZY; Håkanson R
Regul Pept; 1992 Aug; 40(3):323-9. PubMed ID: 1332142
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal polypeptide- and pituitary adenylate cyclase activating polypeptide-mediated control of catecholamine release from chromaffin tissue in the rainbow trout, Oncorhynchus mykiss.
Montpetit CJ; Perry SF
J Endocrinol; 2000 Sep; 166(3):705-14. PubMed ID: 10974664
[TBL] [Abstract][Full Text] [Related]
16. Pituitary adenylate cyclase-activating peptide (PACAP), a new vasoactive intestinal peptide (VIP)-like peptide in the respiratory tract.
Uddman R; Luts A; Arimura A; Sundler F
Cell Tissue Res; 1991 Jul; 265(1):197-201. PubMed ID: 1913779
[TBL] [Abstract][Full Text] [Related]
17. Receptors for pituitary adenylate cyclase-activating peptide in human liver.
Guijarro LG; Rodriguez-Henche N; García-López E; Noguerales F; Dapena MA; Juarranz MG; Prieto JC
J Clin Endocrinol Metab; 1995 Aug; 80(8):2451-7. PubMed ID: 7629241
[TBL] [Abstract][Full Text] [Related]
18. Backup Mechanisms Maintain PACAP/VIP-Induced Arterial Relaxations in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice.
Ivic I; Fulop BD; Juhasz T; Reglodi D; Toth G; Hashimoto H; Tamas A; Koller A
J Vasc Res; 2017; 54(3):180-192. PubMed ID: 28490016
[TBL] [Abstract][Full Text] [Related]
19. Role of Na(+)-K(+)-ATPase in airway smooth muscle relaxation by vasoactive intestinal peptide and pituitary adenylate cyclase activating peptide.
Kanemura T; Tamaoki J; Chiyotani A; Takeyama K; Sakai N; Tagaya E; Konno K
Res Commun Chem Pathol Pharmacol; 1993 Jan; 79(1):11-22. PubMed ID: 8381977
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) induce phosphorylation of the transcription factor CREB in subpopulations of rat pinealocytes: immunocytochemical and immunochemical evidence.
Schomerus C; Maronde E; Laedtke E; Korf HW
Cell Tissue Res; 1996 Dec; 286(3):305-13. PubMed ID: 8929333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
